SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-010912
Filing Date
2021-05-05
Accepted
2021-05-05 16:32:20
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20210331_10q.htm 10-Q 494270
2 EXHIBIT 31.1 ex_246297.htm EX-31.1 14121
3 EXHIBIT 31.2 ex_246298.htm EX-31.2 13938
4 EXHIBIT 32.1 ex_246299.htm EX-32.1 4681
5 EXHIBIT 32.2 ex_246300.htm EX-32.2 4597
12 dmt01.jpg GRAPHIC 28626
  Complete submission text file 0001437749-21-010912.txt   3185387

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmac-20210331.xml EX-101.INS 553340
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20210331.xsd EX-101.SCH 43557
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20210331_cal.xml EX-101.CAL 32822
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20210331_def.xml EX-101.DEF 262254
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20210331_lab.xml EX-101.LAB 225968
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20210331_pre.xml EX-101.PRE 286480
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 21893911
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences